Acta Veterinaria et Zootechnica Sinica ›› 2025, Vol. 56 ›› Issue (5): 2424-2437.doi: 10.11843/j.issn.0366-6964.2025.05.039
• Clinical Veterinary Medicine • Previous Articles Next Articles
ZHU Qiuxiang(), HU Yulin(
), ZHU Xinchao, ZHONG Yongcheng, DING Xiaoqing, JI Jinzhao, WANG Jingyu, JIA Kun, ZHANG Haiyang*(
), LI Shoujun*(
)
Received:
2024-05-29
Online:
2025-05-23
Published:
2025-05-27
Contact:
ZHANG Haiyang, LI Shoujun
E-mail:vet_zhuqiuxiang@163.com;huyulin2023@163.com;zhanghaiyang0429@163.com;shoujunli@scau.edu.cn
CLC Number:
ZHU Qiuxiang, HU Yulin, ZHU Xinchao, ZHONG Yongcheng, DING Xiaoqing, JI Jinzhao, WANG Jingyu, JIA Kun, ZHANG Haiyang, LI Shoujun. Refinement of the Diagnostic Criteria for Acute Stress in Cats and Its Application in Clinical Trials of Gabapentin Tablets[J]. Acta Veterinaria et Zootechnica Sinica, 2025, 56(5): 2424-2437.
Table 1
The table of global sedation score"
得分/分 Score (point) | 具体表现 Presentation |
-3 | 非常易激动(过度活跃;不断移动;间歇或持续发声;安静环境下活跃) |
-2 | 有点易激动(易激动;站立并可能间歇性移动;有或没有间歇性发声;对环境保持警惕;活动水平随着环境的变化而增加;最初易兴奋,但在安静的环境中稳定下来) |
-1 | 轻微的兴奋[轻微兴奋;坐着或站着;有或没有间歇性发声;活动水平随着环境的变化(如遮盖物的移动)而增加;在安静的环境平静] |
0 | 正常(警觉、反应灵敏;胸骨横卧或坐着或站着;不发声;意识到环境的变化,随之增加或不增加活动水平;容易在安静的环境中保持平静) |
1 | 轻微镇静(安静、警觉、反应灵敏;胸骨横卧或坐着;无发声;对环境的变化导致活动水平增加量最少;在安静环境中立即平静) |
2 | 有点镇静(态度平静;胸骨横卧;不发声;对环境的变化有或无意识;环境变化后,活动水平并无变化;在安静环境中立即平静) |
3 | 非常镇静(迟钝;胸骨或侧卧;无发声;除听觉刺激外,对环境变化无意识且无反应;对遮盖物的移动无反应) |
Table 2
The table of clinical data"
组别 Groups | 健康组 The healthy group | 急性应激组 The acute stress group | P值 P value | |
年龄/月Age (month) | 27 (24, 36) | 24 (19, 27) | 0.106 | |
体重/kg Weight | 3.6 (2.8, 4.0) | 3.1 (2.5, 3.5) | 0.233 | |
性别(雄/雌,例)Sex (male/female) | 8/7 | 10/5 | 0.710 | |
品种/% Breed | 英国短毛猫British shorthair | 8 | 7 | 1.000 |
美国短毛猫American shorthair | 4 | 5 | ||
其他品种Others breeds | 3 | 3 |
Table 4
Diagnostic value of serum CRH, ACTH and EPI concentrations in CAS"
指标Indexes | CRH | ACTH | EPI | 联合诊断Combined diagnosis |
曲线下面积AUC | 0.596 | 0.836 | 0.569 | 0.973 |
95%置信区间95% CI | 0.375~0.816 | 0.693~0.978 | 0.359~0.779 | 0.926~1.000 |
截断值Cutoff value | 48.88 pg·mL-1 | 47.54 pg·mL-1 | 10.13 ng·mL-1 | 0.212 |
灵敏度/% Sensitivity | 46.67 | 60.00 | 60.00 | 100.00 |
特异度/% Specificity | 93.33 | 93.33 | 66.67 | 86.67 |
约登指数Youden index | 0.400 | 0.533 | 0.267 | 0.867 |
P值P value | 0.373 | 0.002 | 0.520 | <0.001 |
Table 5
The table of clinical data"
组别 Groups | 赋形剂组 The vehicle group | 加巴喷丁组 The gabapentin group | P值 P value | |
年龄/月Age (month) | 24.0 (22.0, 28.5) | 24.0 (19.0, 35.5) | 0.992 | |
体重/kg Weight | 3.1 (2.5, 3.5) | 3.3 (2.8, 3.6) | 0.144 | |
性别(雄/雌,例)Sex (male/female) | 21/32 | 29/24 | 0.120 | |
品种/% Breed | 英国短毛猫British shorthair | 33 (62.3) | 28 (52.8) | 0.395 |
中华田园猫Domestic cat | 9 (17.0) | 14 (26.4) | ||
美国短毛猫American shorthair | 5 (9.4) | 8 (15.1) | ||
其他品种Others breeds | 6 (11.3) | 3 (5.7) |
Table 6
Blood routine tables before and after treatment in the vehicle group"
项目 Items | 参考范围 Normal range | 检测值Detection value | P值 P value | |
Day 1 | Day 9 | |||
白细胞/(109·L-1) WBC | 5.50~19.50 | 16.17±6.25 | 16.32±6.20 | 0.826 |
中性粒细胞/(109·L-1) NEU | 3.12~12.58 | 10.23 (6.97, 15.60) | 10.54 (6.84, 13.82) | 0.965 |
淋巴细胞/(109·L-1) LYM | 0.73~7.86 | 3.34 (2.68, 4.20) | 3.44 (2.68, 4.59) | 0.626 |
嗜酸性粒细胞/(109·L-1) EOS | 0.06~1.93 | 0.74 (0.50, 1.08) | 0.83 (0.52, 1.24) | 0.392 |
红细胞/(1012·L-1) RBC | 4.60~10.20 | 8.01±1.49 | 7.85±1.60 | 0.356 |
血红蛋白/(g·L-1) HGB | 85.00~153.00 | 113.08±20.10 | 111.55±22.17 | 0.510 |
红细胞压积/% HCT | 26.00~47.00 | 31.57±5.27 | 30.87±6.05 | 0.303 |
血小板/(109·L-1) PLT | 100.00~518.00 | 201.00 (119.00, 311.50) | 181.00 (86.00, 315.50) | 0.286 |
Table 7
Blood routine tables before and after treatment in the gabapentin group"
项目 Items | 参考范围 Normal range | 检测值Detection value | P值 P value | |
Day 1 | Day 9 | |||
白细胞/(109·L-1) WBC | 5.50~19.50 | 14.54 (10.93, 20.01) | 15.37 (9.96, 19.53) | 0.979 |
中性粒细胞/(109·L-1) NEU | 3.12~12.58 | 9.85 (6.51, 13.52) | 9.66 (6.02, 13.58) | 0.828 |
淋巴细胞/(109·L-1) LYM | 0.73~7.86 | 4.66 (3.23, 5.83) | 3.95 (3.01, 5.65) | 0.276 |
嗜酸性粒细胞/(109·L-1) EOS | 0.06~1.93 | 0.80 (0.48, 1.25) | 0.75 (0.49, 1.27) | 0.366 |
红细胞/(1012·L-1) RBC | 4.60~10.20 | 8.85±1.51 | 8.29±1.17## | 0.002 |
血红蛋白/(g·L-1) HGB | 85.00~153.00 | 132.00 (118.00, 140.00) | 120.00 (107.50, 135.50)## | 0.000 |
红细胞压积/% HCT | 26.00~47.00 | 36.60 (31.95, 38.95) | 33.50 (29.10, 37.25)## | 0.000 |
血小板/(109·L-1) PLT | 100.00~518.00 | 208.00 (146.50, 303.00) | 178.00 (107.50, 303.50) | 0.181 |
Table 8
Blood biochemical tables before and after treatment in the vehicle group"
项目 Items | 参考范围 Normal range | 检测值Detection value | P值 P value | |
Day 1 | Day 9 | |||
丙氨酸转氨酶/(U·L-1) ALT | 22.00~84.00 | 59.10 (46.45, 76.00) | 56.40 (46.80, 73.05) | 0.975 |
天门冬氨酸转氨酶/(U·L-1) AST | 18.00~51.00 | 23.70 (18.60, 31.45) | 22.00 (19.00, 27.75) | 0.236 |
碱性磷酸酶/(U·L-1) ALP | 23.00~118.00 | 29.10 (19.55, 43.75) | 31.80 (25.00, 45.25)** | 0.006 |
总蛋白/(g·L-1) TP | 57.00~78.00 | 78.01±5.75 | 74.81±8.18** | 0.002 |
白蛋白/(g·L-1) ALB | 23.00~35.00 | 26.88±4.31 | 26.02±3.85* | 0.021 |
淀粉酶/(U·L-1) AMY | 300.00~1100.00 | 1 446.10 (1 239.00, 1 822.35) | 1 340.10 (1 116.50, 1 606.40)** | 0.000 |
肌酐/(μmol·L-1) CRE | 71.00~159.00 | 96.50 (79.00, 126.80) | 91.60 (78.40, 107.15) | 0.390 |
尿素氮/(mmol·L-1) BUN | 6.28~11.70 | 8.31 (6.93, 10.10) | 7.59 (6.60, 9.34)** | 0.002 |
Table 9
Blood biochemical tables before and after treatment in the gabapentin group"
项目 Items | 参考范围 Normal range | 检测值Detection value | P值 P value | |
Day 1 | Day 9 | |||
丙氨酸转氨酶/(U·L-1) ALT | 22.00~84.00 | 58.40 (43.75, 80.70) | 53.80 (44.20, 84.05) | 0.856 |
天门冬氨酸转氨酶/(U·L-1) AST | 18.00~51.00 | 23.80 (18.60, 31.15) | 21.00 (17.20, 26.85)# | 0.033 |
碱性磷酸酶/(U·L-1) ALP | 23.00~118.00 | 35.90 (26.05, 50.75) | 37.20 (25.75, 49.10) | 0.547 |
总蛋白/(g·L-1) TP | 57.00~78.00 | 77.78±8.86 | 76.02±9.58 | 0.082 |
白蛋白/(g·L-1) ALB | 23.00~35.00 | 28.05±3.98 | 28.09±4.52 | 0.958 |
淀粉酶/(U·L-1) AMY | 300.00~1 100.00 | 1 809.50 (1 306.90, 2 372.60) | 1 435.60 (1 171.30, 2 351.20)## | 0.003 |
肌酐/(μmol·L-1) CRE | 71.00~159.00 | 106.70 (86.45, 128.25) | 104.30 (87.90, 127.15) | 0.863 |
尿素氮/(mmol·L-1) BUN | 6.28~11.70 | 9.12±2.29 | 8.16±1.87## | 0.001 |
Table 10
The table of adverse reaction %"
不良反应类型 Type of adverse reaction | 赋形剂组 The vehicle group | 加巴喷丁组 The gabapentin group | χ2检验P值 The P values of χ2 test |
无力Atony | 1 (1.9%) | 11 (20.8%)** | 0.002 |
共济失调Ataxia | 1 (1.9%) | 8 (15.1%)* | 0.031 |
嗜睡Somnolence | 0 (0) | 6 (11.3%)* | 0.027 |
发声增加Increased vocalization | 1 (1.9%) | 0 (0) | 1.000 |
食欲不佳Poor appetite | 0 (0) | 1 (1.9%) | 1.000 |
过度进食Overeating | 0 (0) | 1 (1.9%) | 1.000 |
1 | DORLAND N W . Dorland's illustrated medical dictionary[M]. aaa: Saunders/Elsevier Health Sciences Division, 1985: 1259. |
2 |
DHABHAR F S , MCEWEN B S . Acute stress enhances while chronic stress suppresses cell-mediated immunity in vivo: a potential role for leukocyte trafficking[J]. Brain Behav Immun, 1997, 11 (4): 286- 306.
doi: 10.1006/brbi.1997.0508 |
3 |
ELLIS J J , STRYHN H , COCKRAM M S . Effects of the provision of a hiding box or shelf on the behaviour and faecal glucocorticoid metabolites of bold and shy cats housed in single cages[J]. Appl Anim Behav Sci, 2021, 236, 105221.
doi: 10.1016/j.applanim.2021.105221 |
4 |
KESSLER M R , TURNER D C . Stress and adaptation of cats (Felis Silvestris Catus) housed singly, in Pairs and in groups in boarding catteries[J]. Anim Welfare, 1997, 6 (3): 243- 254.
doi: 10.1017/S0962728600019837 |
5 |
KESSLER M R , TURNER D C . Effects of density and cage size on stress in domestic cats (Felis Silvestris Catus) housed in animal shelters and boarding catteries[J]. Anim Welfare, 1999, 8 (3): 259- 267.
doi: 10.1017/S0962728600021746 |
6 | 张海洋, 朱秋祥, 高志诚, 等. 猫急性应激模型的建立及诊断标志物的筛选[J]. 畜牧兽医学报, 2023, 54 (3): 1249- 1260. |
ZHANG H Y , ZHU Q X , GAO Z C , et al. Establishment of acute stress model and screening of diagnostic markers in cats[J]. Acta Veterinaria et Zootechnica Sinica, 2023, 54 (3): 1249- 1260. | |
7 |
PANKRATZ K E , FERRIS K K , GRIFFITH E H , et al. Use of single-dose oral gabapentin to attenuate fear responses in cage-trap confined community cats: a double-blind, placebo-controlled field trial[J]. J Feline Med Surg, 2018, 20 (6): 535- 543.
doi: 10.1177/1098612X17719399 |
8 | DI CESARE F , NEGRO V , RAVASIO G , et al. Gabapentin: clinical use and pharmacokinetics in dogs, cats, and horses[J]. Animals (Basel), 2023, 13 (12): 2045- 2062. |
9 |
VAN HAAFTEN K A , FORSYTHE L R E , STELOW E A , et al. Effects of a single preappointment dose of gabapentin on signs of stress in cats during transportation and veterinary examination[J]. J Am Vet Med Assoc, 2017, 251 (10): 1175- 1181.
doi: 10.2460/javma.251.10.1175 |
10 |
CHARMANDARI E , TSIGOS C , CHROUSOS G . Endocrinology of the stress response[J]. Annu Rev Physiol, 2005, 67, 259- 284.
doi: 10.1146/annurev.physiol.67.040403.120816 |
11 |
HABIB K E , GOLD P W , CHROUSOS G P . Neuroendocrinology of stress[J]. Endocrinol Metab Clin North Am, 2001, 30 (3): 695- 728.
doi: 10.1016/S0889-8529(05)70208-5 |
12 | 柯舸, 肖勇, 张弛, 等. 肝硬化食管胃静脉曲张破裂出血伴心肌损伤的危险因素分析[J]. 陆军军医大学学报, 2024, 46 (3): 271- 276. |
KE G , XIAO Y , ZHANG C , et al. Risk factors for myocardial injury in esophagogastric variceal bleeding patients with cirrhosis[J]. Journal of Army Medical University, 2024, 46 (3): 271- 276. | |
13 |
SMITH S M , VALE W W . The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress[J]. Dialogues Clin Neurosci, 2006, 8 (4): 383- 395.
doi: 10.31887/DCNS.2006.8.4/ssmith |
14 |
KVETNANSKY R , SABBAN E L , PALKOVITS M . Catecholaminergic systems in stress: structural and molecular genetic approaches[J]. Physiol Rev, 2009, 89 (2): 535- 606.
doi: 10.1152/physrev.00042.2006 |
15 |
ROMANA-SOUZA B , OTRANTO M , VIEIRA A M , et al. Rotational stress-induced increase in epinephrine levels delays cutaneous wound healing in mice[J]. Brain Behav Immun, 2010, 24 (3): 427- 437.
doi: 10.1016/j.bbi.2009.11.012 |
16 |
SANCHEZ A , TOLEDO-PINTO E A , MENEZES M L , et al. Changes in norepinephrine and epinephrine concentrations in adrenal gland of the rats submitted to acute immobilization stress[J]. Pharmacol Res, 2003, 48 (6): 607- 613.
doi: 10.1016/S1043-6618(03)00241-X |
17 |
WONG D L , TAI T C , WONG-FAULL D C , et al. Epinephrine: a short- and long-term regulator of stress and development of illness: a potential new role for epinephrine in stress[J]. Cell Mol Neurobiol, 2012, 32 (5): 737- 748.
doi: 10.1007/s10571-011-9768-0 |
18 | KAMOHARA H , KAMOHARA T , HIKASA Y . A randomized clinical trial on effects of alfaxalone combined with medetomidine and midazolam in preventing stress-related neurohormonal and metabolic responses of isoflurane-anesthetized cats undergoing surgery[J]. Am J Vet Res, 2022, 83 (11): 1- 10. |
19 | 曹永孝. 药物代谢动力学经典模型的局限与改进[J]. 西安交通大学学报(医学版), 2019, 40 (5): 669- 673. |
CAO Y X . Limitations and improvements of classical models of pharmacokinetics[J]. Journal of Xi'an Jiaotong University (Medical Sciences), 2019, 40 (5): 669- 673. | |
20 |
ADRIAN D , PAPICH M G , BAYNES R , et al. The pharmacokinetics of gabapentin in cats[J]. J Vet Int Med, 2018, 32 (6): 1996- 2002.
doi: 10.1111/jvim.15313 |
21 |
QUIMBY J M , LORBACH S K , SAFFIRE A , et al. Serum concentrations of gabapentin in cats with chronic kidney disease[J]. J Feline Med Surg, 2022, 24 (12): 1260- 1266.
doi: 10.1177/1098612X221077017 |
22 |
KUKANICH B , COHEN R L . Pharmacokinetics of oral gabapentin in greyhound dogs[J]. Vet J, 2011, 187 (1): 133- 135.
doi: 10.1016/j.tvjl.2009.09.022 |
23 |
MILLS P O , TANSEY C O , GENZER S C , et al. Pharmacokinetic profiles of gabapentin after oral and subcutaneous administration in black-tailed prairie dogs (Cynomys ludovicianus)[J]. J Am Assoc Lab Anim Sci, 2020, 59 (3): 305- 309.
doi: 10.30802/AALAS-JAALAS-19-000150 |
24 |
CROWE Y C , GROTH A D , BILLSON F M , et al. Gabapentin reduces stress and does not affect ocular parameters in clinically normal cats[J]. Vet Ophthalmol, 2022, 25 (6): 493- 498.
doi: 10.1111/vop.13018 |
25 |
EAGAN B H , VAN HAAFTEN K , PROTOPOPOVA A . Daily gabapentin improved behavior modification progress and decreased stress in shelter cats from hoarding environments in a double-blind randomized placebo-controlled clinical trial[J]. J Am Vet Med Assoc, 2023, 261 (9): 1305- 1315.
doi: 10.2460/javma.23.01.0044 |
26 |
MCCARTY R . Learning about stress: neural, endocrine and behavioral adaptations[J]. Stress, 2016, 19 (5): 449- 475.
doi: 10.1080/10253890.2016.1192120 |
27 | MATHIESON S , LIN C C , UNDERWOOD M , et al. Pregabalin and gabapentin for pain[J]. BMJ, 2020, 369, m1315. |
28 | 魏春华, 温明春, 王先芳, 等. 3611例哮喘患者血浆皮质醇水平及相关因素的回顾性分析[C]//中华医学会呼吸病学年会——2011(第十二次全国呼吸病学学术会议). 广州, 2011: 509. |
WEI C H, WEN M C, WANG X F, et al. Retrospective analysis of plasma cortisol levels and related factors in 3611 patients with asthma[C]//Annual Meeting of Respiratory Disease of Chinese Medical Association-2011 (The 12th National Respiratory Disease Conference). Guangzhou, 2011: 509. (in Chinese) | |
29 | 衣家奇. 双期增强扫描联合血清皮质醇对肾上腺乏脂性腺瘤及嗜铬细胞瘤的诊断价值[J]. 中国卫生工程学, 2023, 22 (1): 96- 97. |
YI J Q . The diagnostic value of dual-phase enhanced scan combined with serum cortisol in lipid-poor adrenal adenoma and pheochromocytoma[J]. Health Engineering in China, 2023, 22 (1): 96- 97. | |
30 |
MIGEON M . Is gabapentin a safe and effective treatment for nonneuropathic pain?[J]. JAAPA, 2021, 34 (12): 54- 56.
doi: 10.1097/01.JAA.0000794984.26635.42 |
31 |
RUSSO M , GRAHAM B , SANTARELLI D M . Gabapentin-friend or foe?[J]. Pain Pract, 2023, 23 (1): 63- 69.
doi: 10.1111/papr.13165 |
32 |
MESSENGER K M , HOPFENSPERGER M , KNYCH H K , et al. Pharmacokinetics of detomidine following intravenous or oral-transmucosal administration and sedative effects of the oral-transmucosal treatment in dogs[J]. Am J Vet Res, 2016, 77 (4): 413- 420.
doi: 10.2460/ajvr.77.4.413 |
33 |
ALLEN M E , LEBLANC N L , SCOLLAN K F . Hemodynamic, echocardiographic, and sedative effects of oral gabapentin in healthy cats[J]. J Am Anim Hosp Assoc, 2021, 57 (6): 278- 284.
doi: 10.5326/JAAHA-MS-7081 |
34 | PINTO FILHO W A , SILVEIRA L H J , VALE M L , et al. Gabapentin in improvement of procedural sedation and analgesia in oncologic pediatric patients: a clinical trial[J]. Anesth Pain Med, 2019, 9 (5): e91197. |
35 | 彭桂芳. 加巴喷丁的临床应用进展[J]. 中外医疗, 2021, 40 (10): 191- 194. |
PENG G F . Progress in clinical application of gabapentin[J]. China Foreign Medical Treatment, 2021, 40 (10): 191- 194. | |
36 | WIFFEN P J , DERRY S , BELL R F , et al. Gabapentin for chronic neuropathic pain in adults[J]. Cochrane Database Syst Rev, 2017, 6 (6): CD007938. |
37 |
CAI K , NANGA R P , LAMPROU L , et al. The impact of gabapentin administration on brain GABA and glutamate concentrations: a 7T (1)H-MRS study[J]. Neuropsychopharmacology, 2012, 37 (13): 2764- 2771.
doi: 10.1038/npp.2012.142 |
38 |
QU W M , YUE X F , SUN Y , et al. Honokiol promotes non-rapid eye movement sleep via the benzodiazepine site of the GABA(A) receptor in mice[J]. Br J Pharmacol, 2012, 167 (3): 587- 598.
doi: 10.1111/j.1476-5381.2012.02010.x |
39 |
STRUYK A , GARGANO C , DREXEL M , et al. Pharmacodynamic effects of suvorexant and zolpidem on EEG during sleep in healthy subjects[J]. Eur Neuropsychopharmacol, 2016, 26 (10): 1649- 1656.
doi: 10.1016/j.euroneuro.2016.07.002 |
[1] | WANG Qinqian, GAO Zhendong, LU Ying, MA Ruoshan, DENG Weidong, HE Xiaoming. Research Progress of Whole Genome Resequencing in Chinese Indigenous Cattle [J]. Acta Veterinaria et Zootechnica Sinica, 2025, 56(5): 2026-2037. |
[2] | ZHAN Qingyu, DENG Juanli, LIU Hujun, YIN Peng, WANG Hongliang, LI Tiantian. Research Progress on the Toxicology and Detoxification Mechanisms of Zearalenone and Its Derivatives in Corn [J]. Acta Veterinaria et Zootechnica Sinica, 2025, 56(5): 2056-2069. |
[3] | WU Qianhui, ZHANG Yu, ZHANG Taoni, MO Meilan. Research Progress on Mechanism of Lipid Raft Involved in Coronavirus Infection and Its Application [J]. Acta Veterinaria et Zootechnica Sinica, 2025, 56(5): 2112-2122. |
[4] | ZHU Tao, YU Yang, CAI Richun, CHEN Zhiwu, ZHAO Guiping, CUI Huanxian, ZHENG Maiqing. Analysis of the Genetic Characteristics of Clutch Traits in the GF33A Line of Yellow-feathered Broilers [J]. Acta Veterinaria et Zootechnica Sinica, 2025, 56(5): 2136-2147. |
[5] | QIAO Liying, WANG Wannian, ZHANG Li, PANG Zhixu, ZHANG Siying, LI Yifan, LIU Wenzhong. Machine Learning Methods for Sheep Breed Classification Based on Genomic Markers [J]. Acta Veterinaria et Zootechnica Sinica, 2025, 56(5): 2157-2167. |
[6] | YAO Tingting, LI Hao, YAN Huixuan, CAO Yifan, Cirengluobu , Suolangquji , Nimacangjue , ZHAO Li, Danzengluosang , Silangwangmu , Basangzhuzha , CHEN Ningbo. Genetic Diversity of Mitochondrial Genome and Maternal Origin of 10 Cattle Populations in Tibet Autonomous Region [J]. Acta Veterinaria et Zootechnica Sinica, 2025, 56(5): 2194-2202. |
[7] | WANG Yanan, GUO Yaru, JIANG Yanping, CUI Wen, LI Jiaxuan, LI Yijing, WANG Li. Isolation, Identification and Pathogenicity Analysis of Porcine Rotavirus [J]. Acta Veterinaria et Zootechnica Sinica, 2025, 56(5): 2259-2269. |
[8] | HAN Yangrui, XIA Luming, LI Ruifang, ZHANG Manyu, DU Jingying, SUN Qing, LI Zenqiang, ZHAO Hongjin, WANG Quan. Establishment of Lanthanide Microsphere Immunochromatographic Test Strips for the Detection of Toxoplasma gondii Antibodies [J]. Acta Veterinaria et Zootechnica Sinica, 2025, 56(5): 2353-2363. |
[9] | ZHANG Yu, CHENG Fanyu, YU Zhaorong, SHAO Ying, WEI Ningbo, CHEN Fangfang, WANG Zhenyu, SONG Xiangjun, TU Jian, QI Kezong*. Preparation, Identification, and Preliminary Application of Monoclonal Antibodies against Fowl Adenovirus Serotype 4 [J]. Acta Veterinaria et Zootechnica Sinica, 2025, 56(5): 2364-2371. |
[10] | LI Ting, ZHANG Chengcheng, WANG Xiuling, ZHANG Xiaorong, WU Yantao. Isolation and Identification of a Novel Duck Reovirus Strain and the Sequence Analysis of Its σC Gene [J]. Acta Veterinaria et Zootechnica Sinica, 2025, 56(5): 2520-2524. |
[11] | LIAO Yiwen, YE Jingfen, WU Shaobi, CHEN Shixiong, YANG Wan, LUO Xue, YANG Qi. Development of Ring-mediated Isothermal Amplification Technology and Its Application to the Detection of Drug Resistance Genes [J]. Acta Veterinaria et Zootechnica Sinica, 2025, 56(4): 1621-1631. |
[12] | LI Xiaowei, TIAN Wei, LIU Yuan, LI Huixia. Study on the Difference of m6A Methylation Modification in Ovarian Granulosa Cells of Hu Sheep under Heat Stress [J]. Acta Veterinaria et Zootechnica Sinica, 2025, 56(4): 1712-1721. |
[13] | ZHAO Wenxuan, GAO Xue, YU Dawei, GAO Chen, LI Junya. Establishment and Pluripotency Analysis of Induced Pluripotent Stem Cells from Mengshan Cattle [J]. Acta Veterinaria et Zootechnica Sinica, 2025, 56(4): 1731-1743. |
[14] | CAO Liyan, KONG Xiangyu, YUAN Cong, DUAN Yueyue, MA Guoxiang, SHI Lei, ZHANG Yu, WAN Ying, LI Xiangtong, WANG Yating, DU Yu, ZHENG Haixue, WANG Qi. Identifcation of a Novel Linear B-cell Epitope in the Nucleocapsid Protein of Swine Acute Diarrhea Syndrome Coronavirus [J]. Acta Veterinaria et Zootechnica Sinica, 2025, 56(4): 1854-1864. |
[15] | FENG Yongcui, Naing Htet Aung, ZHANG Xinyin, WANG Feiyan, WANG Lele, ZHANG Lu, ZHU Yu, XU Jinjun, TAO Jianping, LIU Dandan. Construction and Evaluation of the Immunoprotection of a DNA Vaccine Targeting Eimeria necatrix Gametocyte Antigen Gene [J]. Acta Veterinaria et Zootechnica Sinica, 2025, 56(4): 1887-1896. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||